Blend GHK-Cu 50mg with BPC-157 10mg

- Free Priority Shipping
- Orders over $75
Buy 2 Get 1 Free Blend GHK-Cu 50mg with BPC-157 10mg :
| Unit Size | 60 mg/vial |
| Unit Quantity | 1 vial |
| Purity (Mass Spectrometry and UV) | 99.98% Nominal Target: 50 mg GHK-Cu + 10 mg BPC-157 |
| Sequence (GHK-Cu) | Gly-His-Lys.Cu.xHAc |
| Sequence ( BPC-157) | H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH |
| Molecular Formula (GHK-Cu) |
C14H23CuN6O4 |
| Molecular Formula (BPC-157) | C62H98N16O22 |
| Appearance | Lyophilized Powder |
| Source | Chemical Synthesis |
| Storage | Lyophilized Blend GHK-Cu 50mg with BPC-157 10mg is stable at room temperature for 90 days, however it is best to store in a freezer at -20°C for any extended period of time. |
| Terms | The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering. |
| COA Verification | Verify this COA on MZ Biolabs → |
Blend GHK-Cu 50mg with BPC-157 10mg
View Research Overview & References
This blend combines two research-grade synthetic peptides, GHK-Cu and BPC-157, supplied together for in vitro laboratory research into cellular signaling and matrix-related mechanisms.
GHK-Cu in Fibroblast Culture Research
GHK-Cu has been examined in cultured fibroblasts across a range of peptide concentrations, with changes in collagen synthesis detectable at concentrations as low as 10-12 M and reaching a maximum at 10-9 M in this cell-based system.1
This wide effective concentration range is a frequently cited feature in laboratory literature discussing GHK-Cu's potency relative to other matrix-modulating research peptides.
BPC-157 Receptor-Independent Mechanism Considerations
Unlike many bioactive peptides that act through a single, well-defined receptor, BPC-157 has not been linked to one confirmed primary receptor in the research literature.
This has led to research interest in receptor-independent mechanisms, including direct effects on intracellular signaling proteins and cytoskeletal components, as a framework distinct from classical receptor-ligand pharmacology used for many other short bioactive peptides in cell-based assay design.
Combined Research Applications
This two-peptide blend is studied for research into matrix-related and cell signaling mechanisms within a single controlled research platform.
Combined use of these peptides remains an area of exploratory laboratory research, and available data on interaction effects between the two components is preliminary and not considered conclusive.
Analytical Verification for Blended Products
For a two-component blend combining a three-residue metal complex with a considerably larger fifteen-residue peptide, analytical verification is understood to require confirmation of both components' individual identity and purity, along with the ratio between them.
Researchers reviewing documentation for this blend are encouraged to look for HPLC or mass spectrometry data resolving GHK-Cu and BPC-157 as separate peaks.
Storage and Handling in the Laboratory Setting
GHK-Cu's copper coordination is understood to confer some resistance to proteolytic degradation, while BPC-157's proline-dense backbone offers a similar, independently derived stability advantage.
Despite these structural differences, the lyophilized blend is stored under sub-zero freezer conditions to preserve both components' integrity prior to use.
How Copper Binds the GHK Tripeptide
GHK is a three-residue sequence of glycine, histidine, and lysine that binds a single copper(II) ion with high affinity. First characterized by Loren Pickart in 1973, it has since become one of the most extensively studied metal-binding peptides in the research literature.
The copper ion is held by three nitrogen atoms: the free amine of glycine, a backbone amide nitrogen between glycine and histidine, and the imidazole ring of histidine. The lysine side chain remains free and extends away from the metal center.
Why the Powder Has a Blue Tint
Copper(II) complexes absorb light in the visible range, which gives GHK-Cu a characteristic blue to blue-violet color. As a result, this blend typically appears as a tinted lyophilized powder rather than the pure white seen with most single-peptide products.
Color intensity can vary slightly between lots and is not, on its own, an indicator of purity.
Structural Contrast Between the Two Components
- GHK-Cu: 3 residues, basic character from histidine and lysine, coordinated to a metal ion
- BPC-157: 15 residues, with four prolines and three acidic residues (one glutamic acid, two aspartic acids)
- Mass difference: a monoisotopic mass near 402 Da for GHK-Cu versus roughly 1419 Da for BPC-157
- Charge difference: GHK-Cu carries a net positive charge, while BPC-157 is net negative near neutral pH
These differences in size, charge, and hydrophobicity are what allow the two components to separate cleanly during reversed-phase HPLC analysis, eluting as distinct peaks.
Mass Ratio Versus Molecular Ratio
The nominal 50 mg to 10 mg target describes a 5:1 ratio by mass. Because GHK-Cu molecules are far smaller than BPC-157 molecules, the vial contains roughly 17 to 18 GHK-Cu molecules for every BPC-157 molecule, a distinction worth noting when interpreting compositional data.
Component Names in the Literature
GHK-Cu appears in published work and supplier catalogs as GHK-Cu, GHK Copper, Copper Tripeptide-1, and Copper Peptide. BPC-157 is referenced as BPC-157, Pentadecapeptide BPC 157, and Bepecin. Each name refers to the corresponding sequence shown in the specification table above.
Important Notice
These peptides are synthesized, blended, and supplied strictly for in vitro laboratory research purposes only. They are not intended for human consumption, diagnostic use, or therapeutic application, and have not been evaluated for safety or efficacy in humans.
References
1. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346.










